Company news
Twist Bioscience Corporation (NASDAQ:TWST) news
Twist Bioscience Corporation news releases on 6ix. Latest, Oct 15, 2024: Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
Press releases — page 2
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
October 14, 2024
Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance
September 11, 2024
Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels
September 8, 2024
Twist Bioscience to Present at Baird Global Healthcare Conference 2024
August 26, 2024
Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb
August 7, 2024
Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis
August 4, 2024
Twist Bioscience Reports Fiscal Third Quarter 2024 Financial Results
August 1, 2024
Twist Bioscience Announces Clinical Progression of Pure Biologics’ Antibody Candidate Discovered Using Twist’s Antibody Libraries
July 17, 2024
Twist Bioscience to Report Fiscal 2024 Third Quarter Financial Results on Friday, August 2, 2024
July 10, 2024
Twist Bioscience Expands High-Throughput IgG Antibody Portfolio with Launch of CHO Express Antibodies
July 9, 2024
Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A
July 8, 2024
Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
June 5, 2024
Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
June 3, 2024
Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
May 12, 2024
Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
May 1, 2024
Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
April 17, 2024
Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
March 27, 2024
Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
March 4, 2024
Twist Bioscience Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
February 5, 2024
Twist Bioscience and Element Biosciences Collaborate on Exome Sequencing Solutions for AVITI System
February 5, 2024
Twist Bioscience Unveils Differentiated Ultra High-Throughput Library Preparation Solution at AGBT
February 4, 2024
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
February 1, 2024
Twist Bioscience Expands Express Genes Rapid Synthesis Service
January 23, 2024
Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024
January 15, 2024
Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
January 7, 2024
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
January 4, 2024
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference
December 17, 2023
Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results
November 16, 2023
Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service
November 13, 2023
Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference
November 12, 2023
Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023
November 1, 2023
Twist Bioscience Launches Full Length Unique Dual Index Adapters to Enable PCR-free Whole Genome Sequencing
October 30, 2023
Twist Bioscience Enters into Antibody Discovery and Licensing Option Agreement with Bayer of up to $188 Million
October 4, 2023
Twist Bioscience Appoints Mark Buck as Senior Vice President, Operations
October 2, 2023
Twist Bioscience and IMIDomics Collaborate to Discover Antibodies for Applications in Immune-Mediated Inflammatory Diseases
September 26, 2023
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
August 30, 2023
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
August 21, 2023
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
August 6, 2023
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
August 3, 2023
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
July 19, 2023
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
July 17, 2023
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
June 25, 2023
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
June 19, 2023
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research
May 30, 2023
Twist Bioscience Appoints Robert Werner as Chief Accounting Officer
May 22, 2023
Twist Bioscience Launches Portfolio of RNA Sequencing Tools
May 21, 2023
Twist Bioscience to Present at ITF World 2023
May 9, 2023
Twist Bioscience Reports Fiscal Second Quarter 2023 Financial Results
May 4, 2023
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
April 26, 2023
Twist Bioscience Enters into Third Collaboration with Astellas to Support Antibody Discovery for Immunotherapies
April 19, 2023